KAPLAN MATTHEW L. received a stock award from NUVECTIS PHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/12/2025ACC: 0001104659-25-058919
+30K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
30K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+30K
Price / share
—
Trade value
—
% of position
35.8%
6/12/2025
83.76K→113.76K
Total
Net shares
+30K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/12/2025 | A · Award | +30K | — | — | 35.8% | 83.76K | 113.76K |
| Total | +30K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported